Summary & Overview
HCPCS A9540: Technetium Tc-99m MAA for Lung Perfusion Imaging
HCPCS Level II code A9540 represents a diagnostic radiopharmaceutical: Technetium tc-99m macroaggregated albumin (MAA), per study dose up to 10 millicuries. This agent is commonly used for lung perfusion imaging, including ventilation-perfusion assessments that inform diagnosis and management of pulmonary embolism and other perfusion abnormalities. As a billable supply, A9540 captures the material component of the nuclear medicine study and is relevant for accurate cost reporting and procedure claims.
Key payers in the national context include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical use and site-of-service considerations, payer coverage patterns, typical billing modifiers and claim line practices, and related coding considerations for nuclear medicine imaging workflows. The publication highlights common billing scenarios where A9540 appears on claims, how it interacts with technical and professional components of imaging services, and typical documentation elements that support medical necessity.
This analysis is intended to inform coding, revenue cycle, and clinical teams about where A9540 fits in imaging service lines, what to expect from major payers, and which operational checkpoints influence correct billing and reimbursement. Data not available in the input will be noted where applicable.
Billing Code Overview
HCPCS Level II code A9540 describes Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries. This item is a radiopharmaceutical diagnostic agent used in nuclear medicine studies that evaluate pulmonary perfusion, typically as part of a ventilation-perfusion (V/Q) scan or other lung perfusion imaging procedures.
Service Type: Diagnostic radiopharmaceutical administration for nuclear medicine imaging
Typical Site of Service: Hospital outpatient radiology/nuclear medicine department or outpatient imaging center
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult referred for a ventilation–perfusion (V/Q) scintigraphy or lung perfusion scan to evaluate pulmonary embolism, chronic thromboembolic pulmonary hypertension, preoperative assessment for lung resection, or assessment of regional pulmonary perfusion. The patient arrives at a nuclear medicine department in an outpatient imaging center or hospital radiology/nuclear medicine suite. After identification and consent, a technologist confirms indications and allergies, reviews recent contrast studies or anticoagulation status, and prepares the radiopharmaceutical. A dose of Technetium Tc-99m MAA (up to 10 millicuries per study dose, billed as A9540) is drawn under radiation safety protocols and injected intravenously. Imaging is performed with a gamma camera to obtain planar and/or SPECT images of pulmonary perfusion. A nuclear medicine physician interprets the study, generates a report, and documents findings and the injected activity. The technologist documents lot number, activity administered, route, time, and any complications. Typical sites of service are outpatient hospital radiology departments, freestanding imaging centers, and inpatient hospital units when clinically indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when reporting the physician interpretation separate from the technical service provided by the facility/technologist. |